Penumbra (NYSE: PEN) net income
Penumbra reported a net profit of $177.7m for fiscal 2025, 1,168.1% more than in fiscal 2024 ($14.0m). Its net margin was 12.7%. Earnings per share were $4.57.
Fiscal 2025 is the highest of the 10 fiscal years on record for Penumbra. The biggest drop was in fiscal 2024, −84.6%. It reported a loss in 2 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $177.7m | +1,168.1% | 12.7% | $4.57 |
| 2024 | $14.0m | −84.6% | 1.2% | $0.36 |
| 2023 | $91.0m | — | 8.6% | $2.37 |
| 2022 | −$2.0m | −137.9% | −0.2% | −$0.05 |
| 2021 | $5.3m | — | 0.7% | $0.14 |
| 2020 | −$15.7m | −132.4% | −2.8% | −$0.44 |
| 2019 | $48.5m | +634.1% | 8.9% | $1.39 |
| 2018 | $6.6m | +41.7% | 1.5% | $0.19 |
| 2017 | $4.7m | −68.6% | 1.4% | $0.14 |
| 2016 | $14.8m | — | 5.6% | $0.49 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Penumbra net income compared with its sector
By net income for its latest fiscal year, Penumbra ranks 96th of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Penumbra, 12.7%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 94th | Organon | $187.0m | 3.0% |
| 95th | Bio-Techne | $181.9m | 15.0% |
| 96th | Penumbra | $177.7m | 12.7% |
| 97th | Coherus Oncology | $168.0m | 398.4% |
| 98th | Concentra Group Holdings Parent | $166.4m | 7.7% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Penumbra
- How much did Penumbra earn in fiscal 2025?
- Penumbra reported a net profit of $177.7m for fiscal 2025. In fiscal 2024 it reported a net profit of $14.0m.
- What are the earnings per share of Penumbra?
- They were $4.57 in fiscal 2025, compared with $0.36 in fiscal 2024.
- What is the net margin of Penumbra?
- In fiscal 2025 its net profit was 12.7% of its revenue.
- What was the most profitable year for Penumbra?
- Of its last 10 fiscal years, fiscal 2025, with $177.7m.
- Where does Penumbra rank in its sector by net income?
- It ranks 96th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Penumbra come from?
- From the annual report (Form 10-K) that Penumbra files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Penumbra files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Penumbra: the Penumbra page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.